Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2025, Aquestive Therapeutics (AQST) reported revenue of $8.72 million, down 27.6% over the same period last year. EPS came in at -$0.24, compared to -$0.17 in the year-ago quarter.The reported revenue represents a surprise of -28.14% over the Zacks Consensus Estimate of $12.14 million. With the consensus EPS estimate being -$0.17, the EPS surprise was -41.18%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations ...